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Abstract Epithelial–mesenchymal transitions (EMTs) are es-
sential manifestations of epithelial cell plasticity during tumor
progression. Transforming growth factor-β(TGF-β) modu-
lates epithelial plasticity in tumor physiological contexts by
inducing EMT, which is associated with the altered expression
of genes. In the present study, we used DNA micro-array
analysis to search for differentially expressed genes in the
TGF-β1 induced gallbladder carcinoma cell line (GBC-SD
cells), as compared with normal GBC-SD cells. We identified
225 differentially expressed genes, including 144 that were
over-expressed and 81 that were under-expressed in the
TGF-β1 induced GBC-SD cells. NT5E (CD73) is the most
increased gene, while the Fc fragment of the IgG binding
protein (FcGBP) is the most decreased gene. The expression
patterns of these two genes in gallbladder adenocarcinoma and
chronic cholecystitis tissue were consistent with the micro-
array data. Immunochemistry and clinicopathological results
showed that the expression of NT5E and FcGBP in gallblad-
der adenocarcinoma is an independent marker for evaluation
of the disease progression, clinical biological behaviors and
prognosis. The data from the current study indicate that
differential NT5E and FcGBP expressions could be further
evaluated as biomarkers for predicting survival of patients with
gallbladder cancer and that NT5E and FcGBP could be prom-
ising targets in the control of gallbladder cancer progression.
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Introduction
Gallbladder cancer (GBC) is the most common malignant
tumor of the biliary tract, characterized by early lymph node
invasion and distant metastases. It tends to be an aggressive
tumor that spreads early and 90 % of GBC patients are
presented at an advanced, inoperable stage (Husi and Grant
2001; Schrimpf et al. 2005). Most patients have died within
the first year postoperatively. Many improvements have been
made in diagnoses and treatments for GBC. However, the
survival and outcome of most patients has not dramatically
changed. Therefore it is very important to find new targets for
the development of new therapeutic agents, as well as GBC
biomarkers for monitoring both progression and treatment of
the disease.
Genetic alterations resulting in altered mRNA levels have
been described in GBC. Historically, a number of these genes
have been identified, such as p53 tumor suppressor gene,
KRAS, BRAF, FHIT, CDKN2, HER2 and so on (Wistuba
and Gazdar 2004). It has been reported that the expression
level of Topoisomerase II was increased in GBC and
vimentin was found to be significantly promoted in gallblad-
der carcinoma metastasis. Moreover, musashi-1, ALDH1,
PEG10 and TSG101 were identified as carcinogenesis, pro-
gression and poor-prognosis-related biomarkers for gallblad-
der adenocarcinoma (Aebersold and Mann 2003; Li et al.
2004; Walikonis et al. 2000; Yoshimura et al. 2004). Due to
its complicated background, it is very helpful to identify
additional genes that may be up- or down-regulated in
GBC, in order to better understand the process of metastasis
and provide additional markers of diagnosis and treatments for
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the disease. As we all know, DNA microarray technology
permits simultaneous analysis of the expression of large num-
bers of human genes (Mariadason et al. 2003). Furthermore,
Chen et al. (2006) used DNA micro-arrays to identify poten-
tial markers for GBC and to examine the genetic differences
between early and advanced GBC. When the GBC isolates
were compared to the normal control samples, they identified
4,682 genes, including 2,270 that were over-expressed genes
and 2,412 that were under-expressed genes in the GBC.
Similarly in our previous studies, a total of 814 genes were
overexpressed in the GBC cells revealed by DNA microarray
technology, while 1,474 genes were underexpressed (data not
shown). Even though so many differentially expressed genes
were found, it would cost a great deal to screen out by
conventional methods the valuable genes that are associated
with the invasion and metastasis of GBC. In the present
study, GBC-SD cells were treated with TGF-β1 to induce
epithelial–mesenchymal transition (EMT) in order to specifi-
cally identify target genes of EMT during GBC. Theoretically,
with TGF-β 1 induced EMT, a large number of genes
unrelated to invasion and metastasis of GBC may be filtered
and a designated study of the genes related to the mechanism
of GBC invasion and metastasis can be carried out
(Chen et al. 2006).
EMT is the transdifferentiation of epithelial cells into mes-
enchymal cells and this process has been shown to play an
important role in the acquisition of metastatic phenotypes by
carcinoma cells. Proteins inducing the occurrence of EMT in
tumor cells are various, such as transforming growth factor-β
TGF-β). TGF-β has a dual role in carcinogenesis. It can act as
a tumor suppressor in early lesions, while contributing to the
malignant progression by promoting invasion and metastasis
in many advanced tumors (DeGiorgis et al. DeGiorgis et al.
2005; Stevens et al. 2003). Activation of TGF-β signaling is
sufficient to induce EMT in cultured epithelial cells (Phillips
et al. 2001).
NT5E is also called CD73 (ecto-5'-nucleotidase). It is a
glycosyl phosphatidylinositol (GPI)-anchored purine salvage
enzyme expressed on the surface of human T and B lympho-
cytes and catalyzes the final step in the hydrolysis of ATP to
adenosine. It serves as a “master switch” between ATP-
consuming and ATP-generating extracellular pathways
(Collins and Grant 2007). However, NT5E has functions
(such as an adhesive molecule in promoting tumor invasive-
ness in human glioblastoma) that are not related to its catalytic
activity (Fukata et al. 2005; Vandenberghe et al. 2005). It has
been found that CD73 is highly expressed in many human
solid tumors and has participated in tumor neovasculariza-
tion, invasiveness, metastasis and shorter life expectancy
(Spychala 2000). In addition, NT5E expression and its gener-
ation of adenosine may relate to breast cancer progression and
increased expression of CD73 in ER-negative cells may serve
as a novel marker for more aggressive breast carcinoma
(Kabbani et al. 2007; Kato et al. 2007; Rinner et al. 2007).
Despite intensive efforts, the roles of NT5E in GBC have
remained elusive.
FcGBP was first identified as an Fc portion of the IgG
molecule binding site in intestinal and colonic epithelia, gall
bladder, cystic duct, bronchus, submandibular gland, cervix
uteri and in fluids secreted by these cells in humans. It might
play a role in cell protection and anti-inflammation in tissues
(Selbach and Mann 2006). O'Donovan et al. showed that
FcGBP was differentially expressed in normal thyroid tissue,
thyroid adenomas and thyroid carcinomas (Grant 2006). It has
also been found that FcGBP expression was significantly
reduced in both human and transgenic adenocarcinomamouse
prostate (TRAMP) prostate carcinomas (Witzmann et al.
2005). However, studies currently available in literature do
not find FcGBP to have been involved in the pathogenesis of
GBC.
In our research, DNA microarrays were applied to investi-
gate the differentially expressed genes between GBC cells
with TGF-β1 induced EMT and normal GBC cells. Then, an
in-vivo study of gallbladder adenocarcinoma and chronic
cholecystitis was performed to verify the results obtained in
the microarray study and further investigate the role of




The human gallbladder cancer cell line GBC-SD was pur-
chased from the Shanghai Cell Institute National Cell Bank
(Shanghai, China). Cells were cultured in RPMI1640 medium
(supplemented with 15 % fetal bovine serum (FBS) and 1 %
penicillin/streptomycin) in a humidified incubator with 5 %
carbon dioxide at 37 °C. To induce EMT, cells were cultured
for 24 h and then incubated in media containing 10 μg/l of
TGF-β1. Cells were collected for further analysis.
Microarray procedures
Human 22 K Oligo Chips comprising 21,522 open reading
frames were obtained from CapitalBio (Beijing, China). The
cDNA probes obtained from GBC-SD cells were labeled with
Cy5. An equal amount of cDNA probe obtained from
TGF-β1 induced GBC-SD cells was labeled with Cy3. For
hybridization, purified Cy3- and Cy5-labeled cDNA probes
were mixed and applied to a microarray following incubation
at 42 °C for 18 h under humid conditions. Fluorescent images
of hybridized microarrays were scanned with a LuxScan -
10KA device (CapitalBio, Beijing, China). Images were ana-
lyzed with LuxScan 3.0 (CapitalBio, Beijing, China) in
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accordance with the manufacturer’s instructions. DNA micro-
array overall linear calibration was made according to Cy5
and Cy3 and analysis was made of the fluorescent signal
strength of Cy5 and Cy3; finally the ratio of Cy5/Cy3 was
calculated. The Cy5/Cy3 ratio of a certain spot in the DNA
microarray represented the expression abundance ratio of the
mRNA between TGF-β1 induced GBC-SD cells and
GBC-SD cells without TGF-β1 induction. Genes with weak
fluorescent signal were deleted. The criteria of screening
for differential expressed genes were as follows: upreg-
ulated genes with a ratio≥2.0, downregulated genes with a
ratio≤0.5.
RNA extraction and real-time polymerase chain reaction
(PCR) analysis
Total RNA was extracted using RNAVzol (VIGOROUS,
Beijing, China) and treated with DNase I (Invitrogen, USA).
cDNA synthesis was performed using the cDNA Synthesis
kit (Fermatas,USA), according to the manufacturer’s
instructions.For the real-time PCR assay, cDNAwas subjected
to PCR amplification. Primers were designed to generate a
PCR product less than 200 bp. The primer sequences were as
follows: NT5E, forward:5'- TCGGGTTTTGAAATGGATAA
AC -3' and reverse, 5'-TCAGGAATGCTGCTGTTTAGAA-
3'. FCGBP, forward:5' - CCTATGGAGCTGGTGGATACTC
-3' and reverse:5' - GCATAGTCAGAATGGATCACCA -3'.
CDH1, forward:5' -CTGGACCATTCAGTACAACGACC-3'
and reverse:5' -CTTCTCCGCCTCCTTCTTCATC-3', VIM,
forward:5' -AATGACCGCTTCGCCAACTA-3' and re-
verse:5' -GCTCCTGGATTTCCTCTTCG-3', GAPDH, for-
ward:5'-CAAGGTCATCCATGACAACTTTG-3 and re-
verse:5'-GTCCACCACCCTGTTGCTGTAG-3'. Thermal
cycling conditions were: 94 °C for 2 min, followed by
30 cycles of 94 °C for 45 s, 55 °C for 30s and 72 °C for
10min. Expression levels were normalized to GAPDH house-
keeping gene. The visualized bands were quantified by
BANDSCAN software. The average absolute intensity was
presented as ± s. The statistical significance of differences was
analyzed using Student’s t -test. P values<0.05 were consid-
ered to be statistically significant.
Western blotting
Total proteins extracted from GBC and chronic cholecystitis
tissues were lysed with strong RIPA sample buffer (50 mmol/l
Tris–HCl, pH 8.0, 150 mmmol/ l NaCl, 1 mmol
phenylmethylsulfonyl fluoride, 50 mmol/l DTT, and 1 % Tri-
ton X-100) on ice for 30 min. The supernatants were collected
after centrifugation at 14,000 g at 4 °C for 10 min. After
protein concentration was determined (Bradford Protein Assay
kit, Beyotime Institute of Biotechnology,China), 50 μg pro-
teins were mixed with 2×SDS loading buffer and incubated at
100 °C for 10 min before loading and were subjected to
electrophoresis in 11.5 % polyacrylamide gels. Proteins were
electrotransferred onto PVDF membranes (Invitrogen, USA)
in transfer buffer. Non-specific binding to the membrane was
blocked for 1 h at room temperature with 5 % non-fat milk in
tris buffer saline buffer (TBS) (20 mmol/l Tris–HCl,
150 mmol/l NaCl and 0.1 % Tween-20). Membranes were
then incubated overnight at 4 °C with the following primary
antibody: anti- NT5E (Santa Cruz, USA), anti-FcGBP (Santa
Cruz, USA), followed by incubation with horseradish
peroxidase-conjugated secondary antibody (Protintech, USA)
respectively. Membranes were then washed with TBS buffer
and signals visualized using the enhanced chemiluminescence
system (Santa Cruz, USA). The visualized bands were quanti-
fied by BANDSCAN software. The signal intensity was nor-
malized to β-actin. The average absolute intensity was pre-
sented as ±s. The statistical significance of differences was
analyzed using Student’s t-test. P values<0.05 were consid-
ered to be statistically significant.
SiRNA and transfection
The three pairs of 19-nt siRNA duplexes targeting NT5E
corresponding to the respective coding regions were designed
and synthesized by GenePharma. NT5E siRNA-1 was raised
against the sequence corresponding to nt 363–382 (5_-GACC
AAAGCTGATCTCATA-3_), NT5E siRNA-2 corresponded
to nt 792–811 (5_-GAAAGAAGAGGAAGATAAA-3_) and
NT5E siRNA-3 corresponded to nt 1343–1362 (5_-CAGA
AGACAAGGAGAATTA-3). All siRNA sequences were
compared against human sequences deposited in GenBankTM
databases with BLAST (basic local alignment search tool)
searches using NCBI (National Center for Biotechnology
Information) tools.
For siRNA experiments, GBC-SD cells were grown over-
night in 12-well plates. Cells were transfected with 100 pmol
of siRNA using LipofectamineTM 2000 (Invitrogen) as
instructed by the manufacturer. Forty-eight hours after trans-
fection, the most effective recombinant vector was selected
using a fluorescence microscope.
Cell proliferation and apoptosis assays
GBC-SD cells transfected with siRNA specific to NT5E or
with a nonspecific control siRNA were plated in triplicate in
96-well plates at a density of 1×105 cells/well. Cell prolifer-
ation was analyzed by a methyl thiazolyl tetrazolium (MTT)-
based assay. For each MTT assay, the medium in each well
was replaced with 200 μl of medium containing 20 μl MTT.
After 4 h of incubation, the MTT-containing medium was
removed, 200 μl of DMSO was added to each well and the
plate was agitated for 10 min in the dark to dissolve the MTT-
formazan crystals. Sample absorbance was recorded at
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570 nm. The above experiments were performed in triplicate
and the results are presented as the mean ± SD.
Transwell cell migration assay
Cell migration was assayed with 24-pore size Transwell mi-
gration chambers (Costar). Matrigel was thawed at 4 °C
overnight and then diluted in RPMI1640 serum free-cold cell
culture media. Then, 100 ul of the diluted matrigel was put
into the upper chamber of a 24-well Transwell that was
incubated at 37 °C for at least 4 to 5 h for gelling. GBC-SD
cells transfected with siRNA specific to NT5E or with a
nonspecific control siRNA were digested by Trypsin/EDTA,
washed 3 times with RPMI1640 containing 1 % FBS and
resuspended in media containing 1 % FBS at a density of 106
cells/ml. Then, 100 ul of the cell suspension was put onto the
matrigel.The lower chamber of the transwell was filled with
600 ul of culture media containing 5 ug/ml fibronectin, as an
adhesive subtrate. After being incubated at 37 °C for 24 h,
transwells were removed from 24-well plates and stained with
Diff-Quick solution (Fischer Scientific). Non-migrated cells
were removed using a cotton swab and the migrated cells were
then photographed using a microscope (MZ16FA; Leica)
equipped with a digital camera (DC 500; Leica). To quantify
the number of migrated cells, stained cells were subsequently
extracted and detected on a standard microplate reader at
560 nm (Spectra-MAX190; Molecular Devices).
Wound healing assay
GBC-SD cells transfected with siRNA specific to NT5E or
with a nonspecific control siRNA were detached by trypsin,
resuspended in RPMI1640 medium and plated in triplicate at
3 × 105 cells per well of a 24-well plate. After the cell became
confluent, cells were starved in a RPMI serum-free medium
for 24 hrs; then one artificial wound per well was scratched
into the monolayers with a sterile plastic 10-μl micropipette
tip to generate a uniform wound. After wounding, the culture
medium was removed and cells were washed at least twice in
PBS. Wound closure was monitored by digital photographs
taken in a phase-contrast microscope (Nikon Diaphot 300,
Tokyo, Japan) across the wound at the moment of wounding
and at 24 hrs post-wounding.
Case selection
Samples of 108 patients who underwent surgical resection or
biopsy from 1996 to 2011 were identified as having gallblad-
der adenocarcinoma. Twetny-four of the patients (22.2 %)
were male and 84 patients (77.8 %) were female, with an
average age of 54.5±10.6 years. All diagnoses were based on
morphological criteria, immunohistochemical staining and
clinical findings. The histopathologic subtypes of the 108
adenocarcinomas were as follows: 36 cases (33.3 %) of
well-differentiated adenocarcinoma, 31 cases (28.7 %) of
moderately-differentiated adenocarcinoma, 30 cases
(27.8 %) of poorly-differentiated adenocarcinoma and 11
cases (10.2 %) of mucinous adenocarcinoma. Fifty-nine pa-
tients (55.0 %) had regional lymph node metastasis, in 58
patients (54.0 %) accompanied by gallstones. Surgery includ-
ed radical resection for 32 adenocarcinomas (32.0 %), pallia-
tive surgery for 44 adenocarcinomas (44.0 %) and biopsy for
24 cases (24.0 %) without resection. We selected 46
peritumoral tissues (distance from cancer>3 mm) from 108
gallbladder adenocarcinoma tissues. Among the 46
peritumoral tissues, ten tissues were normal, one tissue
showed mild dysplasia, 12 tissues showed moderate dysplasia
and 14 tissues showed severe dysplasia.
From 1996 to 2011, we gathered other specimens of 80
patients with cholecystectomy diagnosed as adenoma (30),
poly (15), simple chronic cholecystitis (15), or chronic chole-
cystitis with stones (20). General data were as follows:
There were 12 male patients (40.0 %) and 18 female ones
(60.0 %) in the adenoma group, with an average
age of 48.5±9.4, maximum diameter 0.9–2.2 cm. Path-
ological findings revealed normal epithelia in five cases
mild dysplasia in ten cases, moderate dysplasia in nine
cases and severe dysplasia in six cases.
There were five male patients (33.3 %) and ten female
ones (66.7 %) among the poly group, with an average age
of 50.8±9.6, maximum diameter 0.8–0.15 cm. Patholog-
ical findings revealed adenomatous polyp, among which
ten cases were normal epithelia to mild dysplasia and five
cases were moderate dysplasia to severe dysplasia.
There were 15 male patients (42.9 %) and 20 female ones
(57.1 %) in the chronic cholecystitis groups, with an
average age of 43.2±12.4, maximum diameter 0.9–
2.2 cm. Pathological findings revealed normal epithelia
in 11 cases, mild dysplasia in 12 cases, moderate dyspla-
sia in seven cases and severe dysplasia in five cases.
The specimens were prepared as paraffin-embedded tissues
and then 4 μm sections were made for further study. This
study was carried out in accordance with the Declaration of
Helsinki (2000) of the World Medical Association and it was
approved ethically by the Second Xiangya Hospital attached
to Central South University. Informed written consent forms
were obtained from all subjects who participated in the
study.
EnVision™ immunohistochemistry
An EnVision™ Detection Kit was purchased from Dako
Laboratories (Carpinteria, CA, USA). 4-μm sections were
cut from routinely paraffin-embedded tissues, deparaffinized
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and incubated with 3 % H2O2 in the dark for 15 minutes, then
digested by EDTA-trypsin for 15 minutes. The sections were
incubated with primary antibody (anti- NT5E and anti-
FcGBP) for 60 minutes, then second antibody for 30 min after
being incubated 3 times with PBS. Solution A was added to
the sections for 30 minutes. After DAB staining and
haematoxylin counter-staining, the slides were dehydrated with
alcohol (70–100% concentration) and then incubated 3 times in
xylene. Finally, neutral balsam was mounted with the slides.
Ten random fields were examined per section. The percent of
positively stained cells relative to the total number of cells was
counted. The strength of staining was rated on a scale of 1 to 3.
A score of 1 represents little to no positive staining or uncertain
weak staining; 2 represents weak to moderate staining; 3 rep-
resents moderate to strong staining. A section was determined
as positive for NT5E or FcGBP when the percent of positively
stained cells was >10 % and staining strength >2. The few
sections where percent positive staining was 5 % to 10 % and
staining strength was 3 were also regarded as positive.
Statistical analysis
Data were analyzed using SPSS 13.0. The inter-relationship
NT5E or FcGBP expression with histology or clinical factors
was analyzed using χ2 or Fisher’s exact test. Kaplan–Meier
and time series test (log-rank test) were used for univariate
survival analysis. The Cox proportional hazards model was
used for multivariate analysis and to determine the 95 % con-
fidence interval.
Results
Identification of genes differentially expressed in the TGF-β1
induced GBC-SD cells and normal GBC-SD cells
To explore the mechanism of invasion and metastasis of
gallbladder cancer, DNA microarray technology was applied
to investigate the differentially expressed genes between GBC
cells with TGF-β1 induced epithelial mesenchymal transition
(EMT) and normal GBC cells. Results revealed by DNA
microarray showed that Hex, interior label and external label
were normal in positive control and negative in negative
control, with an authentic repetitiveness of housekeeping
genes (ratio CV≤0.3) and leak rate ≤3‰, indicating that the
data are valid without genomic DNA contamination. The
distribution of differential gene expressions in TGF-β1 in-
duced and control GBC-SD cells is shown in a scatter plot
form in Fig. 1. These items suggested that the samples were
not pollution. Two hundred and twenty-five differentially
expressed genes were identified between GBC-SD cells with
and without TGF-β1 induced EMT, among which 144 genes
were up-regulated (Supplement Table 1) and 81 genes were
down-regulated (Supplement Table 2) in GBC cells after
TGF-β1 induced EMT. NT5E is the most increased gene
while FcGBP is the most decreased gene.
After that, we performed further gene ontology (GO), path-
way and bioinformatics analyses using the molecule annotation
system (MAS 2.0). A hypergeometric distribution was applied
for the P-value in GO and pathway investigations. According
to GO classification, differentially expressed genes were
grouped into the pathway of oxidation, protein binding and
cell adhesion (Supplement Fig 2). Most interestingly, revealed
by the pathway analysis, these genes were associated with
the cyclin dependent kinase pathway regulation, intrinsic
prothrombin activation pathway, cell cycle regulation,
phosphoinositide-mediated signaling, etc. Through the analysis
and comparison of the gene expression profile, NT5E and
FcGBP were new differentially expressed genes during
TGF-β1 induced EMT. After reference review, we thought that
NT5E and FcGBP might play important roles in the invasion
and metastasis of gallbladder cancer with TGF-β1 induced
EMT. So these two genes were chosen for further research.
Validation of the microarray data by RT-PCR andWestern blot
The in-vivo study of gallbladder adenocarcinoma and chronic
cholecystitis was performed to verify the expression levels of
NT5E and FcGBP in invasion and metastasis of gallbladder
adenocarcinoma. The total RNA and protein were both ex-
tracted from specimens from 15 patients diagnosed as having
gallbladder adenocarcinoma and 15 patients diagnosed as
having chronic cholecystitis. The mRNA transcription and
protein expression levels of NT5E and FcGBPwere evaluated
by RT-PCR andWestern blot respectively. Figure 1 shows that
NT5E mRNAwas significantly lower in chronic cholecystitis
than in gallbladder adenocarcinoma (0.225±0.021 vs 1.012±
0.019, P <0.01), while FcGBP mRNA was significantly
higher in chronic cholecystitis than in gallbladder adenocarci-
noma (0.321±0.017 vs 0.078±0.020, P <0.01). Western blot
demonstrated that NT5E expression was significantly higher in
gallbladder adenocarcinoma than in chronic cholecystitis
(0.826±0.011 vs 0.412±0.017, P <0.01), while the expression
of FcGBP protein was significantly lower in gallbladder ade-
nocarcinoma than in chronic cholecystitis (0.084±0.017 vs
0.187±0.025, P <0.01). NT5E expression was upregulated
and FcGBP expression was downregulated in gallbladder ade-
nocarcinoma compared to chronic cholecystitis in vivo, which
was consistent with the DNA microarray data (Fig. 1).
NT5E regulates the expression of EMT-associated gene
in GBC-SD cells
We examined the effect of NT5E on the expression of key
regulators of EMT including CDH1 and VIM. Real-time PCR
analysis indicated that the expression of NT5E and VIM gene
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in the GBC-SD cells transfected with pRNA-siNT5E-1 was
significantly lower than in the unrelated sequence vector
transfected group and non-transfected group (P <0.01), while
the expression level of CDH1 gene in the GBC-SD cells
transfected with the pRNA-siNT5E-1 vector was significantly
higher than others (P <0.01), as shown in Fig. 2. The expression
of NT5E , CDH1 and VIM mRNA had no statistical signifi-
cance between the group that was transfected with the unrelated
sequence vector and the non-transfected group (P >0.05).
Down-regulation of NT5E affects cell viability
To determine whether siRNA-mediated knockdown of NT5E
affected cell viability, an MTT assay was performed to inves-
tigate cellular proliferation. Figure 3 shows that the prolifera-
tion of GBC-SD cells transfected with pRNA- siNT5E-1 was
slower than that of the unrelated sequence vector group and
non-transfected group cells from the third day and continued
to the sixth day (P <0.05). We determined that the prolifera-
tion of GBC-SD cells transfected with the unrelated sequence
vector and non-transfected had no statistical significance all
the time (P >0.05).
NT5E regulates cell migration
The role of NT5E in regulating cell migration was also exam-
ined. The directed migration of GBC-SD cells transfected
with pRNA- siNT5E-1, unrelated sequence vector transfected
group and non-transfected group cells was compared using an
Fig. 1 RT-PCR and Western blot analysis of the expression level of
NT5E and FcGBP in the gallbladder adenocarcinoma and chronic cho-
lecystitis samples. a , b The total RNAwas both extracted from specimens
of 15 patients diagnosed as having gallbladder adenocarcinoma and 15
patients diagnosed as having chronic cholecystitis. The mRNA transcrip-
tion expression levels of NT5E and FcGBP were evaluated by RT-PCR.
The values were normalized to GAPDH as an internal control. c , d
Western blotting analysis of the levels of NT5E and FcGBP in the
gallbladder adenocarcinoma and chronic cholecystitis samples. Proteins
were separated by 11.5 % SDS-PAGE. The gels were electroeluted to
PVDF membrane and each blot was analyzed with a different antibody:
anti- NT5E and anti-FcGBP. The values were normalized to actin as an
internal control. Mean expression values ± SE are shown.Asterisks indicate
that the expression differences between TGF-β1 induced GBC-SD cells
and normal GBC-SD cells are statistically significant (p<0.05 for Student’s
t-test)
Fig. 2 Transfected with pRNA-siNT5E-1 induced an increase in VIM
mRNA and a decrease in CDH1 mRNA in GBC-SD cells. S : GBC-SD
cells transfected with pRNA-siNT5E-1; C1: GBC-SD cells transfected
with unrelated sequence vector; C2 : non-transfected group. NT5E and
VIM gene (**P<0.01 compared to transfected with unrelated sequence
vector or non-transfected group)
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in-vitro wound assay. In-vitro wound healing assays have
been used with multiple cell types and are a classic and
commonly used method for studying cell migration and the
biology underlying it. As shown in Fig. 4, when a confluent
plate of cells was scratched by a sterile pipette tip, the areas of
the scratch in three groups were the same at 0 hour. After
48 hours, a small number of the GBC-SD cells transfected
with pRNA -siNT5E-1 migrated to the scratch area, while the
cells transfected with unrelated sequence vector pRNAi-NC
and non-transfected cells migrated obviously.
To further confirm the role of NT5E in regulating cell
motility, a transwell chamber invasion assay was used. Con-
sistent with the results from thewound assay, Fig. 5 shows that
the number of GBC-SD cells that were transfectedwith pRNA -
siNT5E-1 that passed through the membrane was lower than
that of the unrelated sequence vector transfected group and
non-transfected GBC-SD cells; the difference was statistically
significant (P <0.05), while there was no statistically signifi-
cant difference between the unrelated sequence vector
transfected group and non-transfected group cells (P >0.05).
Differential expression of NT5E and FcGBP and their
clinicopathological significance in benign and malignant
lesions of the gallbladder
The results (Supplement Table 3) show that NT5E expression
was significantly more up-regulated in gallbladder adenocar-
cinoma (54.6 %) than in peritumoral tissues (30.4 %) and
other benign lesions including adenoma (16.7 %), polyps
(13.3 %) and chronic cholecystitis (11.4 %) (P <0.01). The
ratio of positive FcGBP expression was significantly down-
regulated in gallbladder adenocarcinoma (48.1 %) than in
peritumoral tissues (76.1 %), adenoma (80.0 %), polyps
(86.7 %) and chromic cholecystitis (85.7 %) (P <0.05)
(Supplement Table 3). An atypical hyperplasia in gallbladder
epithelium was observed in the benign lesions with NT5E
positive-expression and/or FcGBP negative-expression.
Fig. 3 Effects of NT5E knockdown using NT5E siRNA on regulation of
gallbladder cancer cell viability. Gallbladder cancer cells were grown and
transfected with NT5E siRNA for 48 h and subjected to cell viability
MTT assay. Data are shown as means ± SEM (n =6)
Fig. 4 siRNA-mediated knockdown of NT5E affected cell migration
in vitro by scratch wound healing assay. a , d GBC-SD cells transfected
with pRNA-siNT5E-1. b , e GBC-SD cells transfected with unrelated
sequence vector. c , f Non-transfected group. a , b , c Wound at time 0
(0 h) for GBC-SD cells incubated with control, serum-free media. d , e , f
24 hrs after wounding for SW756 cells incubatedwith control, serum-free
media. **P<0.01 compared to transfected with unrelated sequence vector
or non-transfected group. Scale bar 100 μm
Fig. 5 siRNA-mediated knockdown of NT5E affected cell migration by
Transwell assay. a GBC-SD cells transfected with pRNA-siNT5E-1. b
GBC-SD cells transfected with unrelated sequence vector. c Non-
transfected group. Cell numbers in three microscope fields (×200) from
each Transwell were counted. Columns, mean of migrating cells done in
triplicate; **P <0.01 compared to transfected with unrelated sequence
vector or non-transfected group. Bars 100 μm
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The NT5E expression in well-differentiated adenocarcinoma,
with small tumor size (diameter<2 cm), no lymph node
metastasis and no peripheral tissue invasion was significantly
down-regulated compared to that in poor-differentiated ade-
nocarcinoma, with larger tumor size (diameter≥2 cm), lymph
node metastasis and peripheral tissue invasion (P<0.5 or P<
0.01) (Fig. 5 and Supplement Table 4). However, the expres-
sion of FcGBP showed a negative correlation in those cases (P<
0.05 or P <0.01) (Fig. 6 and Supplement Table 4). The
monovariable Kaplan–Meier survival analysis showed that
the pathological type, tumor maximum diameter, lymph node
metastasis, peripheral tissue invasion, NT5E and FcGBP
expression were significantly related to the average survival
time of patients with the gallbladder adenocarcinoma (P <
0.05 or P <0.01) (Supplement Table 5). Furthermore, the
survival time of patients with NT5E expression was significantly
shorter than those without NT5E expression (P<0.05) (Fig. 7a).
In addition, FcGBP showed a negative correlation in those cases
(P<0.05) (Fig. 7b). Interestingly, the overall survival time of
cases with NT5E(−)FcGBP(+) was significantly longer than
those with NT5E(+)FcGBP(−) (Fig. 7c). Multivariable Cox
analysis revealed that NT5E expression (P=0.019) or FcGBP
expression (P=0.004) was negatively associated with survival
period and positively associated with mortality after surgery
(Supplement Table 6).
These results showed that the expression of NT5E and
FcGBP in gallbladder adenocarcinoma is an independent
marker for evaluation of the disease progression, clinical
biological behaviors and prognosis. NT5E and FcGBP might
have an important effect on the regulated EMT in malignant
Fig. 6 NT5E and FcGBP expression in benign and malignant lesions of
gallbladder using EnVision immunohistochemistry (original magnifica-
tion ×200). NT5E and FcGBP positive reactions were mainly localized in
the cytoplasm. a Poorly differentiated gallbladder adenocarcinoma,
NT5E(+). b Poorly differentiated gallbladder adenocarcinoma NT5E
(−). c Adjacent tissues to GBC with severe atypical hyperplasia
NT5E(+). d Adjacent tissues to GBC with severe atypical hyperplasia
NT5E(−). e Adenoma with severe atypical hyperplasia NT5E(+). (f)
Adenoma with moderate atypical hyperplasia NT5E (−). g Polyp with
moderate atypical hyperplasia NT5E(+). h Polyp with mild atypical
hyperplasia NT5E(−). i Moderately differentiated gallbladder adenocar-
cinoma FcGBP(+). j Poorly differentiated gallbladder adenocarcinoma
FcGBP(−). k Adjacent tissues to GBC with mild atypical hyperplasia
FcGBP(+). l Adjacent tissues to GBC with severe atypical hyperplasia
FcGBP(−). m Polyp with mild atypical hyperplasia FcGBP(+). n Polyp
with moderate atypical hyperplasia FcGBP(−). o Polyp with moderate
atypical hyperplasia FcGBP(+). p Polyp with severe atypical hyperplasia
FcGBP(−)
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lesions (including GBC). Patients with FcGBP expression had
a better prognosis, while patients with NT5E expression had a
worse prognosis.
Discussion
Gallbladder cancer tends to be the most common malignant
tumor observed in Chile, Japan, and northern India. The main
cause of death in patients is the invasion andmetastasis of cancer.
Cancer is a genetic disease that involves cumulative genetic and
epigenetic alterations, including the activation of oncogenes and
the inactivation of tumor suppressor genes. So gene expression
profiling analysis in cancer can shed light on themechanisms and
pathways that regulate the transition from normal growth to
malignant proliferation. However, only limited information is
currently available concerning the genetic mechanisms that are
involved in the malignant transformation of gallbladder cancer.
In the present research, a DNA microarray was used to identify
the differentially expressed genes in TGF-β1 induced GBC-SD
cells, as compared with normal GBC-SD cells. As we know,
epithelial–mesenchymal transition (EMT) is a key event in
tumor invasion (Dosemeci et al. 2007) and TGF-β1 is an im-
portant inducer of EMT in cancer progression (McClatchy et al.
2007). With TGF-β1 induced EMT, a large number of genes
unrelated to invasion and metastasis of GBC were filtered and a
designated study of the genes related to the mechanism of GBC
invasion and metastasis was carried out in the present study.
Future design of disease process-specific interventions,
such as prevention of tumor progression, will to a large extent
depend on knowledge of mechanisms that determine biolog-
ical specificity of TGF-b actions. We demonstrate that func-
tional genomic approaches provide a new tool to define roles
of critical nodes in TGF-b’s signaling circuitry, based on
inspection of their proximal signaling targets in the context
of well-defined physiological responses. For example, we
show that in the context of TGF-b-induced EMT, 144 upreg-
ulated genes and 81 downregulated genes were identified
using the DNA microarray strategy. NT5E is the most in-
creased gene, while FCGBP is the most decreased gene in
the TGF-β1 induced GBC-SD cells, which suggest that these
two genes may play important roles in EMT.
Our research found the decreased expression of NT5E and
over-expression of FcGBP in the TGF-β1 induced GBC-SD
cells. On the basis of the dramatic fold changes, NT5E and
FCGBP were selected and then reexamined by the use of RT-
PCR and Western blot, which employed specimens of patients
diagnosed as having gallbladder adenocarcinoma and chronic
cholecystitis. The expression pattern of these genes in the tissues
was consistent with the microarray data. We further examined
the expression patterns of NT5E and FcGBP in benign and
malignant lesions of gallbladder by immunochemistry and the
Fig. 7 NT5E and FcGBP
expression and survival in
patients with adenocarcinoma of
gallbladder. a Kaplan–Meier
plots of overall survival in
patients with gallbladder
adenocarcinoma and with NT5E
positive and negative expression.
b Kaplan–Meier plots of
overall survival in patients with
gallbladder adenocarcinoma
and with FcGBP positive and
negative expression. c Kaplan–
Meier plots of overall survival
in patients with gallbladder
adenocarcinoma and with NT5E
(+)(−) and FcGBP (+)(−)
expression
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clinicopathological significance between them is also evaluated.
The elevated expression of NT5E and decreased expression of
FcGBP in gallbladder adenocarcinoma suggested that they are
important markers for progression, clinical biological behavior
and prognosis. Our results also found that patients with high
FcGBP and low NT5E expression in their tumors are more
likely to suffer from invasion and metastatic recurrence. The
monovariable Kaplan–Meier survival analysis suggested that
NT5E and FcGBP expression were significantly related to the
average survival time of patients with gallbladder adenocarci-
noma. Multivariable Cox analysis revealed that NT5E positive-
expression or FcGBP negative-expression was negatively asso-
ciated with survival period. So measurement of NT5E and
FcGBP expression could be used as a tool for early detection
of gallbladder cancer in benign lesions as well as population
screening. These patients may need to be monitored closely for
clinical signs of relapse. Furthermore, wewanted to demonstrate
whether NT5E participated in EMT regulation or not. The
expression of NT5E gene in GBC-SD cells was significantly
inhibited after being transfected with interference vector pRNA-
siNT5E with the up-regulation of CDH1 gene and down-
regulation of VIM gene. This is maybe related to the process
of epithelial–mesenchymal transition of GBC-SD cells. We
found decreased expression of NT5E and overexpression of
FcGBP in malignant gallbladder tissues compared to normal
and benign gallbladder tissues.
However, our current study is a promising proof-of-principle
study. Future studies will confirm our data using a larger sample
size before they can be useful as biomarkers for the prediction
of survival of gallbladder cancer patients. In addition, more
mechanistic studies will be needed to understand their role in
regulation of gallbladder cancer progression and metastasis.
Acknowledgment We are grateful to all members of our group. We
thank Mrs. Chunliang X for helpful comments on the manuscript. The
authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
Aebersold R, Mann M (2003) Mass spectrometry-based proteomics.
Nature 422:198–207
Chen P, Li X, SunY, Liu Z, CaoR, HeQ,WangM,Xiong J, Xie J,WangX
(2006) Proteomic analysis of rat hippocampal plasma membrane:
characterization of potential neuronal-specific plasma membrane pro-
teins. J Neurochem 98:1126–1140
Collins MO, Grant SG (2007) Supramolecular signalling complexes in
the nervous system. Subcell Biochem 43:185–207
DeGiorgis JA, Jaffe H, Moreira JE, Carlotti CG, Leite JP, Pant HC,
Dosemeci A (2005) Phosphoproteomic analysis of synaptosomes
from human cerebral cortex. J Proteome Res 4:306–315
Dosemeci A, Makusky AJ, Jankowska-Stephens E, Yang X, Slotta DJ,
Markey SP (2007) Composition of the synaptic PSD-95 complex.
Mol Cell Proteomics 6:1749–1760
Fukata Y, Tzingounis AV, Trinidad JC, Fukata M, Burlingame AL, Nicoll
RA, Bredt DS (2005) Molecular constituents of neuronal AMPA
receptors. J Cell Biol 169:399–404
Grant SG (2006) The synapse proteome and phosphoproteome: a new
paradigm for synapse biology. Biochem Soc Trans 34:59–63
Husi H, Grant SG (2001) Isolation of 2000-kDa complexes of N-methyl-
D-aspartate receptor and postsynaptic density 95 from mouse brain.
J Neurochem 77:281–291
Kabbani N, Woll MP, Levenson R, Lindstrom JM, Changeux JP (2007)
Intracellular complexes of the beta2 subunit of the nicotinic acetyl-
choline receptor in brain identified by proteomics. Proc Natl Acad
Sci U S A 104:20570–20575
Kato AS, Zhou W, Milstein AD, Knierman MD, Siuda ER, Dotzlaf JE,
Yu H, Hale JE, Nisenbaum ES, Nicoll RA (2007) New transmem-
brane AMPA receptor regulatory protein isoform, gamma-7, differ-
entially regulates AMPA receptors. J Neurosci 27:4969–4977
Li KW, HornshawMP, Van Der Schors RC, Watson R, Tate S, Casetta B,
Jimenez CR, Gouwenberg Y, Gundelfinger ED, Smalla KH (2004)
Proteomics analysis of rat brain postsynaptic density. Implications of
the diverse protein functional groups for the integration of synaptic
physiology. J Biol Chem 279:987–1002
Mariadason JM, Augenlicht LH, Arango D (2003)Microarray analysis in the
clinical management of cancer. Hematol Oncol Clin NAm 17:377–387
McClatchy DB, Liao L, Park SK, Venable JD, Yates JR (2007)
Quantification of the synaptosomal proteome of the rat cerebellum
during post-natal development. Genome Res 17:1378–1388
Phillips GR, Huang JK, Wang Y, Tanaka H, Shapiro L, Zhang W, Shan
WS, Arndt K, Frank M, Gordon RE (2001) The presynaptic particle
web: ultrastructure, composition, dissolution, and reconstitution.
Neuron 32:63–77
Rinner O, Mueller LN, Hubalek M, Muller M, Gstaiger M, Aebersold R
(2007) An integrated mass spectrometric and computational frame-
work for the analysis of protein interaction networks. Nat Biotechnol
25:345–352
Schrimpf SP, Meskenaite V, Brunner E, Rutishauser D, Walther P, Eng J,
Aebersold R, Sonderegger P (2005) Proteomic analysis of synapto-
somes using isotope-coded affinity tags and mass spectrometry.
Proteomics 5:2531–2541
Selbach M, Mann M (2006) Protein interaction screening by quantitative
immunoprecipitation combined with knockdown (QUICK). Nat
Methods 3:981–983
Spychala J (2000) Tumor-promoting functions of adenosine. Pharmacol
Ther 87:161–173
Stevens SM Jr, Zharikova AD, Prokai L (2003) Proteomic analysis of the
synaptic plasma membrane fraction isolated from rat forebrain.
Brain Res Mol Brain Res 117:116–128
Vandenberghe W, Nicoll RA, Bredt DS (2005) Stargazin is an
AMPA receptor auxiliary subunit. Proc Natl Acad Sci U S A
102:485–490
Walikonis RS, Jensen ON, Mann M, Provance DW Jr, Mercer JA,
Kennedy MB (2000) Identification of proteins in the postsynaptic
density fraction by mass spectrometry. J Neurosci 20:4069–4080
Wistuba II, Gazdar AF (2004) Gallbladder cancer: lessons from a rare
tumour. Nat Rev Cancer 4:695–706
Witzmann FA, Arnold RJ, Bai F, Hrncirova P, Kimpel MW, Mechref YS,
McBride WJ, Novotny MV, Pedrick NM, Ringham HN (2005) A
proteomic survey of rat cerebral cortical synaptosomes. Proteomics 5:
2177–2201
Yoshimura Y, Yamauchi Y, Shinkawa T, TaokaM, Donai H, Takahashi N,
Isobe T, Yamauchi T (2004) Molecular constituents of the postsyn-
aptic density fraction revealed by proteomic analysis using multidi-
mensional liquid chromatography-tandem mass spectrometry. J
Neurochem 88:759–768
374 Cell Tissue Res (2014) 355:365–374
